Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.

BACK TO LIST

Patient
Name:	Campos, Eduarda
DOB:	14-DEC-1970 (Age: 54)
Gender:	female
Address:	Strepestraat 280 8600 Lampernisse (Belgium)
ID:	4651-576482-0

Report
Date:	05-JUL-2025

Laboratory
dr Ample, Ex Boulevard du Jardin Botanique 32 1000 Brussels

Requested by
AZ Sint-Jan Brugge-Oostende - Campus Hendrik Serruys Kaïrostraat 84 8400 Oostende (Belgium)

Specimen
Collected:	04-JUL-2025

This seems not to be an HL7 Europe Laboratory Report (type coding LOINC 11502-2)

Chemistry

Test	04 Jul 2025	Reference Range	Unit
Hemoglobin A1c/Hemoglobin.total in Blood	6.8 H	4 - 6	%
Glucose [Mass/volume] in Blood	120.5 H	70 - 100	mg/dL
Urea nitrogen [Mass/volume] in Blood	9.8	7 - 20	mg/dL
Creatinine [Mass/volume] in Blood	0.8	0.6 - 1.1	mg/dL
Calcium [Mass/volume] in Blood	9.0	8.5 - 10.5	mg/dL
Sodium [Moles/volume] in Blood	141.8	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	5.1	3.5 - 5.3	mmol/L
Chloride [Moles/volume] in Blood	109.0	98 - 110	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	28.7	22 - 32	mmol/L
Cholesterol [Mass/volume] in Serum or Plasma	224.7 H	130 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	162.3 H	0 - 150	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	137.4 H	0 - 130	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	54.8	40 - 100	mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine	7.1	0 - 30	mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows persistent hyperglycemia and elevated HbA1c, indicating suboptimal glycemic control. Lipid profile reveals consistently high total cholesterol, LDL, and triglycerides, increasing cardiovascular risk. Renal function and electrolytes are within normal limits, and no significant microalbuminuria is present. Recent stool test for occult blood is at the upper normal limit. Recommend optimization of diabetes and lipid management, and continued monitoring for cardiovascular and renal complications.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows persistent hyperglycemia and elevated HbA1c, indicating suboptimal glycemic control. Lipid profile reveals consistently high total cholesterol, LDL, and triglycerides, increasing cardiovascular risk. Renal function and electrolytes are within normal limits, and no significant microalbuminuria is present. Recent stool test for occult blood is at the upper normal limit. Recommend optimization of diabetes and lipid management, and continued monitoring for cardiovascular and renal complications.